X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

BREAST CANCER RESEARCH

期刊標題檢索 BREAST CANCER R 最新評論: Review speed: 2.0 | Submission hit rate: 25.0 Research focus: Breas... (2024-10-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[BREAST CANCER RESEARCH]您好,您是該頁面的第 28664 位訪客。

期刊簡介
期刊名稱BREAST CANCER RESEARCH BREAST CANCER RESEARCH
LetPub Score
7.3
50 ratings
Rate

Reputation
8.3

Influence
6.5

Speed
7.0

期刊簡稱BREAST CANCER RES
ISSN1465-542X
h-index126
CiteScore
CiteScoreSJRSNIPCiteScore Rank
12.002.5781.865
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q145 / 404
Category: Medicine
Subcategory: Cancer Research
Q137 / 230

自引率 (2023-2024)1.60%自引率趨勢
掲載範囲
Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials.
官方網站https://www.springer.com/journal/13058
在線稿件提交https://www.editorialmanager.com/BRCR
開放訪問Yes
出版商BioMed Central
主題領域ONCOLOGY
出版國/地區ENGLAND
發行頻率
創刊年1999
每年文章數142每年文章數趨勢
黃金OA百分比99.42%
OA Related Info
APC: Yes( GBP2890; USD3990; EUR3290; )
APC waiver:Check Notes
Other charges: No
Keywords: oncology、breast cancer
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ149/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1465-542X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【BREAST CANCER RESEARCH】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE645791
    BIOMATERIALS602216
    Frontiers in Pharmacology504247
    BIOMEDICINE & PHARMACOTHERAPY498675
    JOURNAL OF ETHNOPHARMACOLOGY497136
    Journal of Materials Chemistry B476189
    Frontiers in Immunology461470
    COMPUTERS IN BIOLOGY AND MEDICINE420888
    COLLOIDS AND SURFACES B-BIOINTERFACES419567
    Frontiers in Oncology415935
  •  

    BREAST CANCER RESEARCH BREAST CANCER RESEARCH
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [BREAST CANCER RESEARCH] 的評論撰寫評論
作者: 日光学林


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 21:26:41 評論於
Review speed: 2.0 | Submission hit rate: 25.0
Research focus: Breast cancer
Experience sharing: A very, very bad submission experience, really outrageous. It took almost half a year of back and forth, and there was not enough time before graduation to be cautious about submitting. It took more than two months from submission to review, and then another two months to receive the review comments. The editor gave two weeks to revise and complete the experiments, and after sending it back, it took another two months to receive a rejection email. The author was very dissatisfied, so they emailed the journal to appeal. The chief editor replied with suggestions to add more animal experiments, so it took another two months to add experiments. After resubmitting, it took two more months to decide to send it for review, and after another two months, the review comments came back and it was finally rejected.
(0) 讚! | 日光学林

作者: 日光学林


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 16:27:49 評論於
Dude, I know right, trashy magazines can really delay people from graduating.
(0) 讚! | 日光学林

作者: 珉林辛亥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-09 20:43:35 評論於
Are you always in editor assign?
(0) 讚! | 珉林辛亥

作者: 埃文罗伊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-06 21:36:48 評論於
How many articles in a year?
(0) 讚! | 埃文罗伊

作者: 黑山良畴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-30 15:13:32 評論於
Research focus: Breast cancer experience sharing: Very bad submission experience, wasted me a year of time. After the first major revision, the experiments were all completed, but it was rejected due to language issues. The second submission after revision was not even sent for review for some inexplicable reason. I feel that the journal discriminates against Chinese people more severely. Not recommended for submission
(0) 讚! | 黑山良畴

作者: Molly Newton


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-03 19:12:09 評論於
How are you doing?
(0) 讚! | Molly Newton

作者: Molly Newton


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-03 09:41:12 評論於
You haven't reacted yet.

###
(0) 讚! | Molly Newton

作者: 凌霄昊磊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-01 09:17:25 評論於
Boss, how did the article turn out in the end?
(0) 讚! | 凌霄昊磊

作者: Molly Newton


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-17 19:49:23 評論於
Is the editor assigned after the peer review?
(0) 讚! | Molly Newton

作者: 诗晴小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-07 18:56:04 評論於
Has your status changed?
(0) 讚! | 诗晴小娘子

作者: 龙爪英范


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-28 13:11:31 評論於
How long has this condition been going on for, it's been one month for me
(0) 讚! | 龙爪英范

作者: 巴蜀清霁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-16 13:49:44 評論於
I am too
(0) 讚! | 巴蜀清霁

作者: 玉萧含含


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-25 11:32:35 評論於
How long has this situation been going on? It has been more than a week for me
(0) 讚! | 玉萧含含

作者: 楚楚酱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-05 19:08:05 評論於
How long is the period?
(0) 讚! | 楚楚酱

作者: 半月文墨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-05 10:05:20 評論於
The status has been "editor assigned" all along. Just wondering what your status is?
(0) 讚! | 半月文墨

作者: 仙灵玉霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-02-18 17:43:13 評論於
How long have you been investing in what you dream of now? The Dreamer published by XXX on 2020/02/10, it really is slow
(0) 讚! | 仙灵玉霞

作者: 小光星吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-02-10 15:42:15 評論於
Indeed, take your time
(0) 讚! | 小光星吖

作者: 桃花瑞丹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-05-21 17:16:06 評論於
Has anyone submitted to this magazine?
(0) 讚! | 桃花瑞丹

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 12:27:04 評論於
Made a fortune! A paper was published last year, and this year it surpassed 6 points. My friends, you also need to have such vision
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-15 22:08:15 評論於
What a success! I published an article last year, and this year I broke 6 points. Everyone, you also need to have such insights
(0) 讚! | 凌霄高洁

作者: 努力啊大婉娜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-08-05 08:19:14 評論於
Too slow, crazy
(0) 讚! | 努力啊大婉娜

作者: 努力啊大婉娜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-07-13 20:35:55 評論於
Slowly, slowly, slowly
(0) 讚! | 努力啊大婉娜

作者: 努力啊大婉娜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-07-13 14:25:48 評論於
So slow, really slow, must complain about it
(0) 讚! | 努力啊大婉娜

作者: 中原兴思


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-06-23 18:09:36 評論於
Review speed: 2.0 | Submission acceptance rate: 25.0
Experience sharing: Specialized academic journals are not easy to submit to, very few are able to publish articles on them in China
(0) 讚! | 中原兴思

作者: 努力啊大婉娜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-06-23 12:32:26 評論於
Why is it easier to submit articles in the introduction... didn't feel very good... and the review process is very slow
(0) 讚! | 努力啊大婉娜

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [BREAST CANCER RESEARCH] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*